Lancet Infect Dis. 2013;13:936–45.PubMedCentralPubMedCrossRef 21. Crobach MJ, Dekkers OM, Wilcox MH, Kuijper EJ. European Society of Clinical Microbiology and Infectious Diseases (ESCMID): data review and recommendations for diagnosing Selleckchem C59 wnt Clostridium difficile-infection (CDI). Clin Microbiol Infect. 2009;15:1053–66.PubMedCrossRef
22. Updated guidance on the diagnosis and reporting of Clostridium difficile. Best Practice Guideline 17215. Department of Health 2012, Mar 6. https://www.gov.uk/government/publications/updated-guidance-on-the-diagnosis-and-reporting-of-clostridium-difficile. BIBF 1120 manufacturer 23. Wilcox MH, Planche T, Fang FC, Gilligan P. What is the current role of algorithmic approaches for diagnosis of Clostridium difficile infection? J Clin Microbiol. 2010;48:4347–53.PubMedCentralPubMedCrossRef 24. Guerrero DM, Becker JC, Eckstein EC, Kundrapu S, Deshpande
A, Sethi AK, Donskey CJ. Asymptomatic carriage of toxigenic Clostridium difficile by hospitalized patients. J Hosp Infect. 2013;85:155–8.PubMedCrossRef 25. Curry SR, Muto CA, Schlackman JL, Pasculle AW, Shutt KA, Marsh JW, Harrison LH. Use of multilocus variable number of tandem repeats analysis genotyping to determine the role of asymptomatic carriers in Clostridium difficile transmission. Clin Infect Dis. 2013;57:1094–102.PubMedCrossRef 26. Curry SR, Schlackman JL, Hamilton TM, Henderson TK, Brown NT, Marsh JW, Shutt KA, Brooks MM, Pasculle AW, Muto CA, et al. Peri-rectal swab surveillance for Clostridium difficile using selective broth pre-amplification and real-time PCR detection of tcdB. J VX-680 Clin Microbiol. 2011;49:3788–93.PubMedCentralPubMedCrossRef triclocarban 27. Bartsch SM, Curry SR, Harrison LH, Lee BY. The potential economic value of screening hospital admissions for Clostridium difficile.
Eur J Clin Microbiol Infect Dis. 2012;31:3163–71.PubMedCentralPubMedCrossRef 28. Bouricha M, Samad MA, Levy PY, Raoult D, Drancourt M. Point-of-care syndrome-based, rapid diagnosis of infections on commercial ships. J Travel Med. 2014;21:12–6.PubMedCrossRef 29. Pai NP, Vadnais C, Denkinger C, Engel N, Pai M. Point-of-care testing for infectious diseases: diversity, complexity, and barriers in low- and middle-income countries. PLoS Med. 2012;9:e1001306.PubMedCentralPubMedCrossRef”
“Introduction The development of incremental morbidity and progression to death among infected patients has been a familiar part of physicians’ practice long before the microbial etiology was discovered. However, the transformation in our understanding of a major part of the clinical spectrum of infection-related illness to include a systemic response to infecting microorganisms has been a relatively recent event, with the first attempt to standardize descriptive terminology and its definitions reported in 1992 by Bone et al. [1]. Sepsis is currently defined as a syndrome reflecting patient’s systemic response to an infection [2].